The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ExoLuminate: An observational registry study for detection of pancreatic adenocarcinoma (PDAC) in high-risk or clinically suspicious patients.
 
Harmeet Dhani
Employment - Biological Dynamics
Stock and Other Ownership Interests - Biological Dynamics
Research Funding - Biological Dynamics
 
Juan Pablo Hinestrosa
Employment - Biological Dynamics
Stock and Other Ownership Interests - Biological Dynamics
Research Funding - Biological Dynamics
 
Jesus Izaguirre Carbonell
Employment - Biological Dynamics
Stock and Other Ownership Interests - Biological Dynamics
Research Funding - Biological Dynamics
 
Heath Balcer
Employment - Biological Dynamics
Stock and Other Ownership Interests - Biological Dynamics
Research Funding - Biological Dynamics
 
Razelle Kurzrock
Leadership - CureMatch; CureMetrix
Stock and Other Ownership Interests - CureMatch; CureMetrix; IDbyDNA
Honoraria - AACR; Bicara Therapeutics; Biocom; Chugai Pharma USA; EUSA Pharma; Foundation Medicine; LEK; Merck; NeoGenomics Laboratories; NeoMed; Pfizer; Roche; Turning Point Therapeutics; Wiley
Consulting or Advisory Role - Actuate Therapeutics; AstraZeneca; Bicara Therapeutics; Biological Dynamics; Caris Life Sciences; Daiichi Sankyo; Datar Genomics; Eisai; EOM Pharmaceuticals; Gaido; Iylon; Loxo; Merck; NeoGenomics Laboratories; NeoMed; Pfizer; Prosperdtx; Regeneron; Roche; Soluventis; TD2/Volastra; Turning Point Therapeutics; XBiotech
Speakers' Bureau - NeoGenomics Laboratories; Roche
Research Funding - Biological Dynamics (Inst); Boehringer Ingelheim (Inst); Debiopharm Group (Inst); Foundation Medicine (Inst); Genentech (Inst); Grifols (Inst); Guardant Health (Inst); Incyte (Inst); Konica Minolta (Inst); MedImmune (Inst); Merck Serono (Inst); OmniSeq (Inst); Pfizer (Inst); Sequenom (Inst); Takeda (Inst); Top Alliance BioScience (Inst)
Travel, Accommodations, Expenses - NCI SWOG; TargetCancer Foundation
 
Paul R. Billings
Employment - Biological Dynamics; Natera
Leadership - Biological Dynamics
Stock and Other Ownership Interests - Biological Dynamics; Fabric Genomics; ILiad Biotechnologies; LabCorp; Natera; PAX Neuroscience; Synergenz; Thermofisher Scientific Biomarkers
Consulting or Advisory Role - Bethesda Group; Guidepoint Global
Travel, Accommodations, Expenses - Biological Dynamics; Natera